925 reports of this reaction
4.2% of all CARBOXYMETHYLCELLULOSE SODIUM reports
#2 most reported adverse reaction
EYE PAIN is the #2 most commonly reported adverse reaction for CARBOXYMETHYLCELLULOSE SODIUM, manufactured by Allergan, Inc.. There are 925 FDA adverse event reports linking CARBOXYMETHYLCELLULOSE SODIUM to EYE PAIN. This represents approximately 4.2% of all 22,264 adverse event reports for this drug.
Patients taking CARBOXYMETHYLCELLULOSE SODIUM who experience eye pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE PAIN is moderately reported among CARBOXYMETHYLCELLULOSE SODIUM users, representing a notable but not dominant share of adverse events.
In addition to eye pain, the following adverse reactions have been reported for CARBOXYMETHYLCELLULOSE SODIUM:
The following drugs have also been linked to eye pain in FDA adverse event reports:
EYE PAIN has been reported as an adverse event in 925 FDA reports for CARBOXYMETHYLCELLULOSE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE PAIN accounts for approximately 4.2% of all adverse event reports for CARBOXYMETHYLCELLULOSE SODIUM, making it one of the most commonly reported side effect.
If you experience eye pain while taking CARBOXYMETHYLCELLULOSE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.